Top HEKMA Alternatives

Leapcure is a leader in the realm of patient recruitment and engagement, effectively connecting clinical trial sponsors with qualified participants. Utilizing state-of-the-art technology and innovative strategies, we are dedicated to increasing both the enrollment rates in trials and the overall outcomes for patients. Our platform streamlines the recruitment process, enabling the quick and effective identification of candidates for clinical studies. With a firm commitment to advancing medical research, Leapcure seeks to enhance the inclusivity and significance of clinical trials. We work closely with sponsors and participants alike to facilitate seamless and productive trial experiences, which are essential for the development of new therapies and treatments. By improving access to clinical trials, we are not only creating a more efficient pathway for medical advancements but also empowering patients to play a crucial role in the evolution of healthcare solutions. Ultimately, our mission is to transform the landscape of clinical research for the better.

Castor is an innovative clinical trial platform designed to simplify data management through electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). Its flexible and user-friendly interface allows researchers to collect, manage, and analyze clinical data efficiently across multiple sites and remote patients. Castor’s tools are specifically designed to support decentralized clinical trials (DCTs), enabling real-time data monitoring, remote recruitment, and seamless patient engagement. The platform ensures full regulatory compliance, including HIPAA, GDPR, and 21 CFR Part 11, and is certified for ISO standards. With more than 50,000 global users, Castor continues to improve the speed and quality of clinical trials through integrated, scalable solutions that reduce administrative burdens and accelerate research.

Deep 6 AI transforms the patient enrollment landscape for clinical trials by innovatively altering the methods researchers use to locate appropriate candidates. Utilizing cutting-edge artificial intelligence and natural language processing, DEEP 6 AI adeptly navigates through both structured and unstructured patient data, allowing for the rapid identification of a broader range of well-suited trial participants in just minutes, a stark contrast to the months traditionally required. The platform works in conjunction with prominent health systems, pharmaceutical firms, and contract research organizations, establishing itself as a pivotal element of the clinical research framework and significantly accelerating patient access to trials. Beyond just speeding up enrollment, Deep 6 AI’s groundbreaking software analyzes structured data, such as ICD-10 codes, alongside unstructured clinical information like physician notes, pathology reports, and surgical documents, which can often be challenging to sift through. This thorough examination guarantees that researchers can swiftly locate candidates who fulfill specific requirements, thereby facilitating a quicker rollout of innovative treatments for those in need. Consequently, the integration of this technology not only enhances the efficiency of trial processes but also holds the potential to transform patient care by ensuring timely access to life-saving therapies.

The Medidata Clinical Cloud is an advanced platform crafted to transform the clinical trial experience for patients, sponsors, CROs, and research institutions alike. As the only all-encompassing technological solution dedicated solely to clinical research, this platform covers the entire spectrum of research from its initial stages to final outcomes. It empowers organizations within the life sciences and medical device industries to cut down on development costs, effectively manage risks, and accelerate the launch of new treatments and devices into the market. Regardless of your choice for clinical trial strategies, the advantages of the Medidata Clinical Cloud will be at your disposal. Medidata stands at the leading edge of the digital transformation in clinical research. By harnessing the capabilities of artificial intelligence, machine learning, and advanced analytics, our platform facilitates connections among researchers, study coordinators, investigators, and patients, ultimately speeding up the research process. Furthermore, it features a regulatory-compliant and patient-centric electronic informed consent solution for clinical trials, which improves the experience for everyone involved. This seamless integration of cutting-edge technology not only optimizes operational efficiency but also significantly uplifts the overall quality and integrity of clinical research endeavors. Thus, adopting the Medidata Clinical Cloud means embracing a future where clinical trials are more efficient and patient-focused than ever before.

Antidote acts as a recruitment hub for clinical trials, accelerating the pace of medical research by linking patients with sponsors through specialized recruitment services and an intuitive matching search engine. To combat the issue where over 80% of clinical trials experience setbacks from a lack of participants, Antidote provides sponsors with a centralized, vendor-neutral dashboard that streamlines referrals from various sources, automates the outreach for due diligence and owner letters, and tracks enrollment and return on investment metrics in real time, while delivering valuable analytics on sites and candidates with updates every hour. For patients, Antidote’s smart matching system transforms complex inclusion and exclusion criteria into simple guided Q&A interactions, ultimately presenting them with current clinical trial listings and tailored notifications for new matching opportunities. The platform is built to support both bulk and individual record imports, complete with automated validations, and it boasts user-friendly, multilingual interfaces that are optimized for mobile devices. By simplifying the recruitment process, this innovative solution promotes more effective collaboration between researchers and potential participants, ultimately leading to improved outcomes in clinical studies. Moreover, Antidote’s commitment to accessibility ensures that a diverse range of patients can easily engage with clinical trials, thereby enriching the research landscape.

We develop cutting-edge solutions designed to improve and fortify the clinical trial landscape. Our Enrollment Performance Management platform is preferred by research sites and trusted by sponsors alike. Currently, it is employed by 2,000 research sites across 26 nations and is endorsed by 50% of the world’s leading biopharmaceutical firms. This system allows sites to minimize the time dedicated to repetitive tasks, resulting in smoother patient transitions. By reducing redundant activities, there is a decrease in the number of logs, calls, and emails needed from both research sites and sponsors. With immediate access to detailed pre-screening and enrollment metrics, sponsors can take proactive measures to enhance enrollment efforts. Our highly intuitive patient recruitment and enrollment solution is relied upon by more than 1,800 sites globally. It offers significant insights into recruitment and enrollment, enabling clinical trials to progress more swiftly and with improved predictability. By cutting out unnecessary tasks, sites can redirect their focus on what is truly important: supporting patients. Effortlessly oversee recruitment across various trials, sponsors, or CROs by entering information just once, ensuring it reaches the appropriate channels. This revolutionary strategy not only simplifies the process but also fosters enhanced collaboration among all parties engaged in clinical trials, ultimately contributing to more efficient research outcomes. With such an innovative approach, we are redefining the standards for success in the clinical trial process.

Our strategy for aiding your team starts with our groundbreaking, multi-dimensional platform. Clinical StudyPal serves as a complete, customizable, and patient-centered technology designed to optimize your research processes, rendering them faster, simpler, and more cost-effective. Functioning as a mobile application, it promotes collaboration and boosts interaction between sites and patients, while its web interface facilitates efficient study management backed by comprehensive analytics. Furthermore, it operates as a notification system, ensuring that both patients and the study team are kept well-informed at all times. What advantages might Clinical StudyPal provide for your organization? A more critical question could be, what constraints does it present? With our advanced technology and dedication to patient-focused solutions, our committed team is enthusiastic about supporting yours in establishing a smooth and successful trial experience tailored to your specific requirements. Ultimately, our aim is to empower your research initiatives in every conceivable manner, enhancing the overall effectiveness of your studies. By integrating Clinical StudyPal into your workflow, you can harness the full potential of modern technology to advance your clinical research.

The TCS ADD platform greatly accelerates the process by which pharmaceutical companies launch new products, streamlining clinical research and development to create more agile and secure trials. By promoting digital ecosystems and simplifying complex data management tasks, TCS ADD ensures faster delivery of innovative and effective treatments to patients. This platform leverages the TCS Decision FabricTM, a sophisticated cognitive AI engine, combined with smart analytics and the Internet of Things, providing significant business benefits to the pharmaceutical industry. It is a thorough, metadata-driven solution that adheres to industry standards and meets sponsor requirements for clinical trials. Moreover, this platform harnesses artificial intelligence and machine learning to speed up decision-making, facilitate rapid study initiation, and apply targeted interventions effectively. By digitizing the entire management of clinical trial supply chains while focusing on patient safety, this solution enhances both overall effectiveness and the patient experience during trials. In summary, TCS ADD not only modernizes clinical trial management but also adapts to the changing demands of the healthcare landscape, ensuring a more efficient and patient-centric approach. Through its innovative strategies, TCS ADD is paving the way for the future of clinical research and development.

Accelerate clinical innovation with an AI-enabled Clinical Research Platform that unifies Early Phase CTMS, Late Phase CTMS, and Bioanalytical LIMS into a single, intelligent ecosystem. Purpose-built for pharmaceutical, biotechnology, and CRO organizations, the platform streamlines the complete clinical development lifecycle, from protocol planning, volunteer and patient management, site operations, study execution, and sample lifecycle management to bioanalytical testing, data review, and regulatory reporting. AI-powered capabilities such as intelligent workflow automation, predictive analytics, anomaly detection, smart data validation, and real-time decision support help research teams identify risks early, optimize resources, reduce manual effort, and make faster, data-driven decisions. A key differentiator is its unified CTMS-LIMS architecture, eliminating data silos while ensuring seamless data flow, end-to-end traceability, and operational transparency across clinical and laboratory functions. Configurable workflows, role-based dashboards, automated alerts, and enterprise integrations with EDC, eTMF, ERP, and laboratory instruments enhance collaboration and study oversight. Built on a scalable, GxP-compliant framework supporting GLP, GCP, and 21 CFR Part 11, the platform delivers audit-ready documentation, electronic records, secure access controls, and complete data integrity. By combining AI-driven intelligence with compliance, interoperability, and operational excellence, it empowers sponsors and CROs to accelerate trials, improve study quality, and bring therapies to market faster.

Cloudbyz CTMS is a cloud-based clinical trial management solution built on the Salesforce Cloud platform, specifically designed for sponsors, clinical research organizations (CROs), and clinical sites to oversee the entire spectrum of clinical trial operations. This platform is tailored for the clinical research field, facilitating swift implementation and fostering user engagement. With its user-friendly and clear interface, Cloudbyz CTMS enables rapid deployment, ensuring that teams can hit the ground running. Equipped with a comprehensive array of features, it simplifies the management of all facets of clinical trials, encompassing site management, participant enrollment, documentation, event tracking, milestone monitoring, site visit reports, financial oversight, and inventory control. The advantages of using Cloudbyz CTMS include the following: 1. A secure, reliable, and scalable infrastructure 2. Accelerated realization of value 3. The ability to track study progress and potential risks from the planning stage through to closure 4. Enhanced collaboration among sponsors, CROs, and clinical sites 5. Boosted efficiency for clinical research teams 6. Overall, the platform significantly enhances the clinical trial process, making it more streamlined and effective.

VIPER enhances the screening process by automating the identification of remote patients at the diagnosis phase, thereby ensuring that qualified candidates are enrolled. Utilizing artificial intelligence, the system adeptly aligns patients with precision trials during a vital enrollment window, drawing on lab-agnostic genomic data, electronic medical records (EMR), and pathology data that cater to individual patient profiles and specific research demands. The specialized matching engine rigorously searches for the most appropriate clinical trials that correlate with a patient's diagnosis as soon as it is made. Moreover, VIPER integrates seamlessly into existing workflows, providing real-time notifications about patient eligibility for ongoing trials, which keeps the entire healthcare team informed during this critical period. In addition to these features, VIPER incorporates interactive dashboards that facilitate extensive data mining, enabling the collection and analysis of site and study-level patient information to effectively achieve study key performance indicators (KPIs). This holistic strategy not only boosts the efficiency of trial recruitment but also significantly aids researchers in reaching their objectives with greater success. By continuously refining its processes, VIPER stands to further revolutionize the landscape of clinical trial enrollment.

Signant Health stands as a global frontrunner in evidence generation, dedicated to revolutionizing the clinical trial landscape by engaging patients in their own settings and reimagining the path to validation. They provide a comprehensive suite of clinical technology solutions that encompasses electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and an integrated eClinical platform. Their offerings also include patient engagement tools like an intuitive app, eConsent for effective informed consent practices, and telehealth capabilities. Furthermore, Signant Health specializes in clinical data and analytics services, which involve COA data analysis along with the synthesis and interpretation of data. With over thirty years of experience, the company has been crucial in facilitating numerous clinical trials and has significantly contributed to hundreds of drug approvals, solidifying their position as a dependable partner for sponsors and CROs who aim to deliver high-quality data for informed decision-making and regulatory filing. Their unwavering dedication to innovation is continuously molding the future of clinical research, ensuring that advancements benefit both patients and the medical community at large.

IVR Clinical Concepts is a company dedicated to providing advanced technology for virtual clinical trials and enhancing patient engagement. Their offerings include electronic patient-reported outcomes and patient diaries, which aim to improve data integrity by reducing errors, ultimately leading to faster timelines and lower costs. Additionally, they offer thorough patient recruitment and outreach services that focus on engagement, pre-screening processes, and the acquisition of real-time data. The solutions for subject screening, registration, and randomization are noted for being modular, customizable, and adaptable to various needs. Alongside these capabilities, IVRCC also provides clinical trial material management solutions that help alleviate workload while ensuring better control, as well as eClinical integration services that strive for seamless data unification. Their chart review services deliver valuable insights derived from real-world data and clinical experiences. By emphasizing customized, modular, and flexible solutions, IVRCC aims to enhance the overall patient experience while increasing the success rates of clinical trials. This dedication to innovation and tailored solutions not only strengthens their offerings but also cements IVRCC's role as a prominent leader within the clinical research sector, committed to advancing the effectiveness and efficiency of clinical studies.

Folio3 Digital Health presents a comprehensive Clinical Trial Management Software (CTMS) designed as a web-based solution to significantly improve the overall effectiveness of the clinical trial lifecycle for pharmaceutical companies, contract research organizations (CROs), and research institutions. This innovative platform integrates multiple trial operations, streamlining processes from planning and site management to data collection and reporting while ensuring compliance with international standards such as FDA 21 CFR Part 11, GxP, and HIPAA regulations. With an emphasis on user-friendly interface designs and real-time dashboards, the software is adept at managing clinical trials of all sizes efficiently. Included in the system are specialized modules for initiating studies, which allow users to define protocols, establish timelines, and create budgets through customizable templates that meet their specific requirements. Additionally, the site management capabilities facilitate the tracking of investigator credentials, contracts, and financial transactions, alongside patient recruitment features that simplify the screening process, monitor enrollment, and organize visit schedules, complete with automated reminders to boost participant involvement. The platform's adaptable nature ensures its relevance for a variety of stakeholders in clinical research, ultimately fostering a more cohesive and effective trial management experience, which is essential for advancing medical knowledge and improving patient outcomes. Furthermore, its robust analytics tools provide valuable insights that can enhance decision-making throughout the trial process.

AssisTek emerges as a leader in advanced clinical technology solutions specifically designed for clinical research, offering specialized software that enhances the process of collecting patient data. With a rich history spanning over 25 years, the organization has successfully supported more than 800 clinical research trials across 46 therapeutic areas, including over 500 multinational Phase I–IV trials. Their electronic Clinical Outcome Assessment (eCOA) solutions are marked by scalability, customization, and efficiency, all powered by a dependable cloud-based technology platform. Among their diverse range of products are the TEK eCOA Tablet, adaptable for any questionnaire used in clinical trials, TEK eDiary, which allows for the collection of patient-reported outcomes from home, TEK Configurator for thorough project development in clinical trials, and TEK Study Portal, which integrates eClinical tracking, training, and reporting into a single, user-friendly platform. AssisTek's pioneering systems and services have made them the go-to partner for data collection and analytics, earning the confidence of both patients and healthcare professionals. As they innovate further, AssisTek continues to focus on improving the effectiveness and precision of clinical research methodologies while exploring new avenues to advance the field. Their commitment to excellence ensures they stay at the forefront of technological advancements in clinical research.

In the past, clinical trials and medical research were typically conducted in isolation from the everyday care provided by local healthcare providers and individual practitioners. As a result, many doctors were often unaware of the research efforts underway, leaving their patients in the dark about potential studies that could improve their health outcomes. Elligo has revolutionized this scenario by enabling greater involvement in clinical research through access to an extensive network of over 150 million patients and their detailed data, which allows physicians to introduce research opportunities to patients who might not have otherwise been aware of them. The conventional participant recruitment methods frequently encounter obstacles, including the necessity for patients to travel to designated research locations, which can hinder participation rates. Furthermore, research suggests that patients are more likely to engage in studies when these initiatives are associated with their familiar healthcare providers, highlighting the critical need for the integration of clinical research within established medical settings. By adopting this innovative approach, not only do we bridge the divide between research and patient care, but we also empower individuals to actively engage in meaningful medical advancements that could potentially change their lives. This integration fosters a collaborative environment where patients feel more supported and informed about their treatment options.

Longboat is a cloud-based platform tailored to enhance the efficiency of clinical trials, featuring an integrated Guided Compliance toolset that provides ongoing assistance to users throughout the entire process. By equipping clinical trial site personnel with vital resources, Longboat allows them to focus more on patient care. Moreover, participants can conveniently access important study information and receive timely reminders for upcoming visits. The system streamlines the management of protocol amendments, ensuring they are implemented smoothly and effectively. Additionally, Longboat centralizes the secure exchange of regulated documents among sponsors, CROs, and sites, thereby significantly improving the startup process and alleviating the burden of traditionally tedious tasks for all involved in research. With a unified support platform, all primary stakeholders—including clinical operations teams, monitors, site staff, and trial participants—can access tailored content that meets their specific needs. This holistic strategy guarantees that site staff are well-equipped with the necessary tools and resources to stay engaged and compliant while maintaining a strong focus on participant welfare. In this manner, Longboat not only enhances operational efficiency but also significantly enriches the overall experience for everyone participating in the clinical trial, fostering a more collaborative and effective research environment. By prioritizing user needs, Longboat paves the way for innovative solutions in clinical research management.

Jeeva has developed a revolutionary modular system that operates on a cutting-edge cloud platform. With just one login from any device that supports a browser, users can easily screen patients, offer education, manage enrollment, send SMS and emails, and compile evidence such as electronic patient-reported outcomes. Frustrations with slow patient recruitment and retention are common in the industry, making it imperative to gather solid evidence of safety and efficacy for new investigational medicines to secure approval from regulatory agencies. Jeeva stands out as an invaluable resource for optimizing time and financial resources for patients and biopharma sponsors, particularly in long-term follow-up studies associated with gene therapy. Its innovative approach streamlines processes, ultimately enhancing the efficiency of clinical trials and improving patient care.

AcceleTrial™ removes the guesswork involved in selecting and activating clinical trial sites. It operates on a Study Start-up Management System (SSMS) that prioritizes objective data over self-reported metrics, granting access to a vast repository of thousands of ranked sites around the world. These sites are assessed based on three crucial criteria: their relevant therapeutic knowledge, experience in conducting clinical trials, and available patient data. By utilizing this data-driven approach, you can effectively identify the best-fit sites globally for your clinical trials. The platform also supports a quick activation of these sites for patient enrollment through an automated "push and pull" system that is available in multiple languages. Moreover, it simplifies the document collection process with pre-filled templates and offers real-time activity tracking capabilities. Users can quickly adopt the system since it is cloud-based, requiring very little IT setup or training to get going. Additionally, AcceleTrial™ seamlessly integrates with CTMS or other clinical trial management software, which significantly boosts overall operational effectiveness. This groundbreaking method not only enhances the precision of site selection but also speeds up the entire process of study initiation, ensuring that trials can commence without unnecessary delays. Ultimately, AcceleTrial™ represents a significant advancement in the efficiency and reliability of clinical trial management.

Advancing artificial intelligence to eliminate the necessity for trial and error in healthcare, our digital twins enable rapid and reliable clinical trials. We prioritize research in fields such as neuroscience, immunology, and metabolic disorders, among others. TwinRCTs accelerate full enrollment by requiring fewer participants to achieve the same statistical power as traditional trial methods. This innovative strategy drastically cuts down on the time needed for late-stage study enrollment. Furthermore, TwinRCTs improve the detection of treatment effects in early-stage research by increasing statistical power without needing more participants. They allow researchers to make well-informed decisions based on initial findings and assist in attracting additional participants to clinical trials. By utilizing smaller control groups, TwinRCTs also enhance the likelihood of participants receiving the experimental treatment. Our dedication to ensuring that clinical trials with digital twins achieve regulatory approval remains steadfast. Unlearn is leading the charge in revolutionizing the healthcare industry through the pioneering use of artificial intelligence, crafting and applying cutting-edge generative models that utilize extensive datasets gathered from prior patient studies. This shift in methodology not only optimizes research efficiency but also significantly improves the effectiveness of clinical trials. The future of medicine is being reshaped as we continue to refine these innovative approaches.

The Clinion Clinical Trial Management System (CTMS) offers an intuitive interface that integrates effortlessly with Clinion EDC and Clinion RTSM, providing rapid and thorough access to all elements of the trial process, thereby managing critical aspects such as investigator sites, patient enrollment, serious adverse events (SAEs), protocol deviations, participant inclusions, visit scheduling, investigational product (IP) management, key milestones, financial oversight, custom reporting, and real-time analytics, which collectively enhance quality, mitigate risks, and lower expenses. Designed with a modular architecture, Clinion CTMS includes a variety of modules tailored for specific needs, such as the Admin Module, Project Management, Site Monitoring Activities, Finance and Budget Management, Safety Reporting, IP Inventory Management, Document Management System, Audit/Activity Log, and provides comprehensive dashboards and reports to facilitate efficient trial oversight.

Ripple is an online software platform designed for managing and recruiting research participants in clinical, translational, and social science studies, functioning as an active registry. Created by researchers, Ripple aims to revolutionize the workflow associated with participant management. This comprehensive system facilitates every aspect of research participant management, significantly accelerating the research process from start to finish. By streamlining these workflows, Ripple enhances the efficiency and effectiveness of research initiatives across various scientific fields.

DatStat’s cloud-driven platform centers on the patient, whether in their care journey or during pivotal clinical trials. This cutting-edge solution empowers clinicians and researchers to engage and connect with patients in unprecedented ways. Our offerings for clinical trials and healthcare are anchored in this patient engagement system, employed by some of the most innovative healthcare organizations in the field. The DatStat team works in close collaboration with clients to understand the specific needs of their department, program, or initiative, allowing us to tailor solutions within our web-based platform without the necessity for hard coding. Consequently, we can accelerate the launch of your project more effectively than traditional methods involving custom coding or paperwork. By prioritizing the patient experience, we ensure they can take an active role in the process, which not only improves communication but also enhances your team's overall efficiency—ultimately leading to better outcomes for patients. Thus, our methodology not only optimizes operational workflows but also significantly raises the standard of care delivered to patients, creating a more holistic approach to healthcare.

Accelerating the development of essential drugs while guaranteeing equitable access to high-quality cancer therapies and research for patients globally is paramount. Our innovative technology is revolutionizing patient access to state-of-the-art medications and participation in clinical trials. FICS represents a pioneering software solution that streamlines the collection of regulatory-compliant data during patient treatment. By unifying disparate and previously disconnected applications into a cohesive and efficient platform, FICS enhances the speed and quality of clinical trials, which significantly improves patient outcomes. This transformative approach not only simplifies the trial process but also fosters better collaboration among researchers and healthcare providers.

Discover the leading edge of eSource, CTMS, and eRegulatory software tailored for clinical trial sites with CRIO. Our premier electronic source enables you to capture source data in real-time, significantly reducing paper dependency by up to 90% and improving data quality by 80%. Take control of your operations with CRIO’s intuitive Clinical Trial Management System, which streamlines patient scheduling, financial oversight, and recruitment optimization. We proudly offer innovative electronic regulatory binders, featuring the groundbreaking first-ever electronic delegation log, all fully compliant with 21 CFR Part 11 regulations. For sponsors of clinical trials, our secure online portal allows for complete remote monitoring of your sites’ source data and regulatory documents. Join our vast network of over 500 clinical research sites globally, and benefit from our dedication to enhancing your business by simplifying your site operations. This ensures that your studies progress seamlessly, whether you are on-site or working remotely, allowing you to concentrate on what truly matters: propelling your clinical research efforts forward while ensuring efficiency and accuracy throughout the process.

Dacima Clinical Suite stands out as a cutting-edge web-based platform that integrates electronic data capture (EDC), clinical data management software (CDMS), and clinical trial management tools into a single cohesive solution. Tailored for a variety of applications, it effectively supports clinical trials, epidemiological research, web randomization, electronic patient-reported outcomes (ePRO), surveys, and patient registries. The suite features three essential modules: the Manager (Administrator), the Designer Module, and the Data Entry Module, each playing a vital role in streamlining the research process. This comprehensive approach ensures that users have all necessary tools at their fingertips for efficient data management and analysis.

Phoenix CTMS is an advanced, integrated web application that merges the essential tools of clinical research—Patient Recruitment System (PRS), Clinical Trial Management System (CTMS), and Clinical Data Management System (CDMS)—into a unified, modular platform available for free under an open source license (LGPL 2.1). It is tailored to support the operational workflows and regulatory compliance requirements of academic research centers, contract research organizations (CROs), and hospitals conducting clinical trials across all phases. Developed through years of collaboration with the Medical University of Graz, Phoenix CTMS offers a secure and private encrypted subject registry that protects personally identifiable information (PII) and complies with stringent EU-GDPR standards. The system provides a powerful electronic data capture (EDC) package with unlimited JavaScript scripting on both server and client sides, supporting complex and large electronic case report forms (eCRFs) not easily handled by other solutions. Phoenix CTMS facilitates the management of multiple concurrent clinical trials while efficiently organizing site staff and resources. The platform enables users to formulate complex ad-hoc database queries and supports set operations to identify suitable subject candidates. Its turnkey design allows institutions to deploy the system quickly without integrating several separate applications, enhancing efficiency and data security. This system is ideal for organizations needing a serious open source alternative for clinical data management and trial execution. Phoenix CTMS also helps ensure compliance with ICH GCP (Good Clinical Practice) guidelines, providing a reliable and comprehensive research management tool. Overall, Phoenix CTMS combines flexibility, security, and comprehensive functionality to meet the evolving needs of clinical research professionals.

Clin'form is a robust and flexible electronic Clinical Outcome Assessment (eCOA) platform designed to enhance the efficiency of clinical trials for both participants and research facilities, while also improving data accuracy and expediting processes for research teams. Its adaptability allows it to be utilized across a wide array of protocols and demographics, making it ideal for any questionnaire type, including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries, catering to a diverse demographic from children to seniors. The platform is engineered to accommodate varying population sizes, effectively managing studies that involve small cohorts as well as those with more than 10,000 participants across multiple global locations. Clin'form seamlessly integrates with other clinical systems to create an efficient workflow, supporting a range of data collection methods—including dedicated tablets, smartphones, patients' personal devices, web access via any browser, and in-person interviews. A standout feature is the integrated tele-visit option, which provides flexibility in response to unforeseen changes, along with patient engagement tools that are designed to foster high compliance rates. Furthermore, the intuitive interface of Clin'form ensures that both researchers and participants can navigate the platform with ease, thereby enhancing the overall clinical trial experience and effectiveness. Overall, Clin'form not only streamlines the data collection process but also places a strong emphasis on user experience, making it a valuable asset in clinical research.

We are creating a global marketplace for clinical trials designed to improve visibility, accessibility, and engagement among a diverse range of healthcare professionals and their patients. At Inato, our mission is to make clinical research accessible to every patient, regardless of their background or location. By drawing inspiration from the transformative nature of marketplaces across various sectors, we believe we can achieve similar breakthroughs in clinical research. We shine a light on the multitude of community sites worldwide that are eager to offer more trials for their patients, while empowering these sites to reach their full research potential. Our strategy involves effectively connecting the right sites with appropriate trials on an international scale, simplifying the process for all participants. Our robust support model ensures that sponsors can confidently engage with a wide array of sites globally, aligning research locations with the optimal clinical trial protocols and unleashing their capabilities on a worldwide stage. This collaborative approach not only serves the interests of sites and sponsors but ultimately improves the experience and outcomes for patients involved in clinical trials, fostering a more inclusive research environment. Together, we aim to redefine the landscape of clinical research and make it more equitable for all.

Explore the latest advancements in collecting clinical and patient-reported outcomes data. Our all-encompassing solution goes beyond simple data recording, aiming to create a truly patient-centered research journey. Our eCOA software, built on the foundations of behavioral science, has been meticulously crafted by healthcare experts to cater to the demands of both research sites and sponsors. By focusing on individual identity, motivational triggers, and key goals, we differentiate ourselves from other eCOA platforms. The Datacubed app is designed with an intuitive interface, enabling participants to easily engage with essential elements. It has been noted that the process of data collection is now more efficient than ever, thanks to our flexible, user-friendly, and interactive application. As the necessity for adaptable trial designs becomes increasingly prominent, we offer a range of versatile data collection methods that can be conducted in-person, remotely, or through a hybrid model, accommodating the varied needs of conventional, hybrid, and virtual clinical studies. This level of flexibility guarantees that researchers can capture the most pertinent data, irrespective of the format of the trial. Furthermore, our commitment to continuous improvement ensures that we remain at the forefront of innovation in the field.